Start Date
November 30, 2000
Primary Completion Date
February 28, 2007
Study Completion Date
February 28, 2007
recombinant interferon alfa
semaxanib
University of California Davis Cancer Center, Sacramento
Cancer Center and Beckman Research Institute, City of Hope, Duarte
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles
National Cancer Institute (NCI)
NIH
City of Hope Medical Center
OTHER